Lv4
500 积分 2023-10-27 加入
The current and emerging immunotherapy paradigm in small-cell lung cancer
1天前
已完结
Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives
1天前
已完结
[Chinese expert consensus on gastroenteropancreatic neuroendocrine neoplasms (2022 edition)]
1天前
已完结
Tarlatamab-dlle: A New Hope for Patients with Extensive-Stage Small-Cell Lung Cancer
1天前
已完结
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
4个月前
已完结
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study
7个月前
已完结
皖公网安备34019202002308
